BCL2 and colorectal cancer: HY0110’s antimicrobial and antioxidant effects surpassed those of LGG, and it exhibited strong antiproliferative activity against HT-29 colorectal cancer cells by attenuating β-catenin and BCL-2 expression while upregulating pro-apoptotic markers P62 and c-PARP.